Loma Linda University Clinical Trial Center — Loma Linda, California

Loma Linda University Clinical Trial Center is a clinical research site located in Loma Linda, California, United States 92354.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Loma Linda University Clinical Trial Center has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Juvenile Idiopathic Arthritis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA).

Sponsors: Pfizer, InflaRx GmbH, Brigham and Women's Hospital.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Loma Linda

Browse all research sites in California · View every site in Loma Linda

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Loma Linda University Clinical Trial Center?

Loma Linda University Clinical Trial Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Loma Linda University Clinical Trial Center conducted?

Loma Linda University Clinical Trial Center has 4 clinical trials on record, with 1 currently active. Their work covers Juvenile Idiopathic Arthritis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA).

Is Loma Linda University Clinical Trial Center accredited by Crixeo Clinical Trials?

Loma Linda University Clinical Trial Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Loma Linda University Clinical Trial Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.